[
    [
        {
            "time": "2021",
            "original_text": "年中国医药零售行业市场规模与竞争格局分析 药店连锁化发展大势已成【组图】",
            "features": {
                "keywords": [
                    "医药零售",
                    "市场规模",
                    "竞争格局",
                    "药店连锁化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "零售"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中国医药零售行业市场规模与竞争格局分析 药店连锁化发展大势已成【组图】",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "近期",
            "original_text": "大参林控股股东补充质押250万股公司股份 近三年信披考评非B即C 股票质押异常",
            "features": {
                "keywords": [
                    "大参林",
                    "股东质押",
                    "股票质押",
                    "信披考评"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "大参林控股股东补充质押250万股公司股份 近三年信披考评非B即C 股票质押异常",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08",
            "original_text": "财信证券医药生物行业2021年8月月度报告：坚守高景气，关注高性价比个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "高景气",
                    "高性价比",
                    "个股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "财信证券医药生物行业2021年8月月度报告：坚守高景气，关注高性价比个股",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        }
    ]
]